RA
IDYA icon

Rosalind Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Rosalind Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,900
Closed -$237K – 41
2025
Q3 		$237K Buy
35,900
+15,900
+80% +$385K 0.08% 36
2025
Q2 		$68K Buy
+20,000
New +$384K 0.03% 36

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Rosalind Advisors's IDYA Position: Q4 2025 in Review

Rosalind Advisors sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 350,000 shares — an estimated $9.52M sold.

Rosalind Advisors first reported a position in IDYA in Q1 2025 and held it in 3 quarters. The position peaked at $11.5M in Q1 2025. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

  • Rosalind Advisors reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
  • Rosalind Advisors sold 350,000 IDEAYA Biosciences shares in Q4 2025, an estimated $9.52M.
  • Rosalind Advisors first reported a position in IDEAYA Biosciences in Q1 2025 and held it in 3 quarters.
  • Rosalind Advisors's IDEAYA Biosciences position peaked at $11.5M in Q1 2025.
  • 246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Rosalind Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.